Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 801 participants.
Also called NCT02643381
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 801 participants
- Registry
-
NCT02643381
-
- Other papers using this trial's data
- Etomidate versus ketamine for emergency endotracheal intubation: a randomized clinical trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02643381. Randomized; no masking; primary purpose treatment. Start 2016-06-06 (actual); primary completion 2020-12-01 (actual). Results posted on 2021-12-15.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial
- Acronym
- EvK
- Condition
- Cardiopulmonary Arrest
- Condition
- Respiratory Arrest
- Intervention (Drug)
- Etomidate
- Intervention (Drug)
- Ketamine
- Intervention (Procedure)
- Emergency Endotracheal Intubation
- Intervention (Device)
- Mechanical Ventilation
- Lead sponsor
- University of Texas Southwestern Medical Center
Record details
- Record id
cardio:ct-nct02643381- Content hash
43cab0267249269f34c541629a92e72a416acccb1fa0f7ef1639d2bb63178cfc